Navigation Links
Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
Date:6/17/2013

e the overall acceptance of compounding and develop new opportunities for compounders to serve patients."

Gus Bassani, Pharm.D., Vice President of Consulting, R&D and Formulations with PCCA, and also an Imprimis board member, said, "Buderer Drug Company and its novel drug technologies are just one example of the depth of creativity and innovation possessed by PCCA's members. We've desired to create a pathway for our members' innovations that have commercial potential to get FDA approval. Imprimis has developed this pathway for PCCA pharmacy members and we hope to see more in the future." 

Baum added, "We will continue to be open to the ideas, innovation and unique 'proximity to the patient' of the more than 4,000 compounding pharmacy members that are a part of the proprietary PCCA network worldwide."

About Imprimis Pharmaceuticals, Inc. Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a specialty pharmaceutical company focused on the commercial development of compounded drug formulations. Through its exclusive strategic relationship with Professional Compounding Centers of America (PCCA), the largest compounding pharmacy organization in North America, Imprimis expects to use its proprietary Accudel drug delivery technologies, as well as proprietary drug formulations for new indications and market data obtained through PCCA, to identify and pursue pharmaceutical development opportunities where there is a significant unmet medical need utilizing the FDA 505(b)(2) regulatory pathway. Imprimis' most near term drug candidate, Impracor, is a Phase III product candidate that utilizes the Accudel topical cream formulation to deliver the active drug ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its localized anti-
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
2. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
3. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
4. Imprimis Announces Key Leadership Appointments
5. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis to Begin New Study of Its Topical Analgesic Drug
8. Imprimis Names Two Experts To Its Science And Regulatory Board
9. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
10. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
11. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly ... and painless for patients to self-inject prescription drugs in the ... including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... grow to $220B by 2018, according to analysts.   Many of ...
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... BURLINGTON, Mass., Dec. 12, 2011 /PRNewswire-iReach/ -- ... Financial. Tom joined Ametros as executive vice president in ... in the workers, compensation managed care industry. He served ... Medical, vice president of national occupational health for Kaiser ...
... Ontario, Dec. 12, 2011  Valeant Pharmaceuticals International, Inc. ... at a special meeting of shareholders of Afexa ... today in Calgary, Alberta, the shareholders of Afexa ... subsidiary, 1625907 Alberta Ltd. (the " Offeror ") ...
Cached Medicine Technology:Ametros Financial Names Thomas Ash as CEO 2Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc. 2Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc. 3
(Date:4/18/2014)... device is being prepped to enter the battle ... of certain diseases in remote areas, thanks in ... investigations aboard the International Space Station on the ... concept of capillary flow to diagnose infectious diseases ... Ph.D., a researcher at Northwestern University in Evanston, ...
(Date:4/18/2014)... Johns Hopkins University School of Medicine researchers have been ... for diabetes, Novo Nordisk announced this month. Of the ... and Obesity Biologics Science Forum Program, only four projects ... Hopkins researchers. They are Jonathan Powell, M.D., Ph.D.; G. ... , Jonathan Powell, a professor of oncology, will use ...
(Date:4/18/2014)... Simon Fraser University psychologists have made a brain-related ... of attention-deficit disorders. , This discovery opens up ... hinder or suppress a specific brain activity that ... distraction. , The Journal of Neuroscience ... by John McDonald, an associate professor of psychology ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... the first genetic variant specifically associated with the ... around 10-15 per cent of all breast cancer ... breast cancer sub-type, called invasive lobular carcinoma, gives ... this particular kind of breast cancer, which can ... today (Thursday) in the journal PloS Genetics ...
Breaking Medicine News(10 mins):Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3
... of death in Lake County , ... Evanston, IL (Vocus) March 12, ... a $1 million commitment to the Lake County Health Department and Community ... to addressing the steadily growing problem of diabetes in the county. , ...
... National Center for Creative Aging (NCCA) will feature certification on ... of the "NCCA-MetLife Foundation Creativity Matters: Health, Wellness, and ... March 30, 31, April 1 . Anne ... at the University of Wisconsin and Founder and ...
... Well-known for its preventive care initiatives, state,s largest ... American Lung Association to provide medical professionals the ... Live Well programCHARLESTON, W.Va., March 12 The ... UniCare Health Plan of West Virginia, Inc. (UniCare) ...
... finding and help fight obesity , , THURSDAY, March 12 (HealthDay ... may keep children more active and help combat the continued ... For every park found within a half-mile of home, a ... odds of taking part in leisure walking increased by 60 ...
... What,s Safe to Eat and Who,s Most At RiskLANSING, ... food safety legislation under debate in the U.S. Senate ... that Americans are more concerned than ever when it ... alarmingly unaware of the long-term side effects of Salmonella, ...
... the forthcoming 24th Annual EAU Congress in Stockholm (SE), which ... organizing three Meet the Expert sessions. These are press meetings ... in the Press Centre of the congress venue. In these ... the experts their questions practically one-on-one. , The first session,s ...
Cached Medicine News:Health News:NorthShore University HealthSystem Launches Diabetes Outreach Program for Lake County's Medically Underserved 2Health News:NorthShore University HealthSystem Launches Diabetes Outreach Program for Lake County's Medically Underserved 3Health News:NorthShore University HealthSystem Launches Diabetes Outreach Program for Lake County's Medically Underserved 4Health News:National Center for Creative Aging Features Timeslips in 'Creativity Matters' Symposium on Health, Wellness, and the Arts 2Health News:UniCare Health Plan of West Virginia Providing Assistance for Asthma Education Training 2Health News:UniCare Health Plan of West Virginia Providing Assistance for Asthma Education Training 3Health News:Kids Who Live Near Green Spaces Seem to Walk More 2Health News:Food Safety Expert: Americans Not Aware of Ongoing Risk & Complications of Salmonella Poisoning 2Health News:Food Safety Expert: Americans Not Aware of Ongoing Risk & Complications of Salmonella Poisoning 3Health News:Meet the expert sessions at the 24th Annual EAU Congress 2
... The optimal combination of performance ... New 4x5 mL swinging bucket rotor. ... 0.2 ml to 8.3 ml, with ... drive, very quiet operation, rotor imbalance ...
... versatility, and environmental safety are ... LE-80 K Ultracentrifuge from Beckman ... Optima centrifugation technology, the LE-80 ... effectively provide advanced capability for ...
... power for small-volume samples. With the ability ... removing chylomicrons (fat particles in lipemic samples), ... lipemic clarification. Lipemic samples can be cleaned ... sendouts. The easy-to-operate tabletop centrifuge: Reaches ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: